BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16526552)

  • 41. Update for nurse anesthetists--part 3--cyclodextrin introduction to anesthesia practice: form, function, and application.
    Welliver M
    AANA J; 2007 Aug; 75(4):289-96. PubMed ID: 17711159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aqueous solubility and true solutions.
    Loftsson T
    Pharmazie; 2010 Jun; 65(6):404-7. PubMed ID: 20614686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting permeability coefficient in ADMET evaluation by using different membranes-interaction QSAR.
    Liu J; Li Y; Pan D; Hopfinger AJ
    Int J Pharm; 2005 Nov; 304(1-2):115-23. PubMed ID: 16182478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
    Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
    Hegge AB; Másson M; Kristensen S; Tønnesen HH
    Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-Assembly of Cyclodextrins and Their Complexes in Aqueous Solutions.
    Ryzhakov A; Do Thi T; Stappaerts J; Bertoletti L; Kimpe K; Sá Couto AR; Saokham P; Van den Mooter G; Augustijns P; Somsen GW; Kurkov S; Inghelbrecht S; Arien A; Jimidar MI; Schrijnemakers K; Loftsson T
    J Pharm Sci; 2016 Sep; 105(9):2556-2569. PubMed ID: 26975246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.
    Fahr A; van Hoogevest P; May S; Bergstrand N; S Leigh ML
    Eur J Pharm Sci; 2005 Nov; 26(3-4):251-65. PubMed ID: 16112849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclodextrins: application in different routes of drug administration.
    Shimpi S; Chauhan B; Shimpi P
    Acta Pharm; 2005 Jun; 55(2):139-56. PubMed ID: 16179128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.
    Brewster ME; Vandecruys R; Peeters J; Neeskens P; Verreck G; Loftsson T
    Eur J Pharm Sci; 2008 Jul; 34(2-3):94-103. PubMed ID: 18420390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Roles of dynamic metal speciation and membrane permeability in metal flux through lipophilic membranes: general theory and experimental validation with nonlabile complexes.
    Zhang Z; Buffle J; van Leeuwen HP
    Langmuir; 2007 Apr; 23(9):5216-26. PubMed ID: 17391055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of vesicle electrokinetic chromatography as an in vitro assay for the estimation of intestinal permeability of pharmaceutical drug candidates.
    Pascoe RJ; Masucci JA; Foley JP
    Electrophoresis; 2006 Feb; 27(4):793-804. PubMed ID: 16411277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Part of the concentrations boundary layers in creations the electrical properties of cell containing two polymeric membranes and binary electrolyte solutions].
    Werner H; Slezak A
    Polim Med; 2007; 37(4):3-19. PubMed ID: 18572875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
    Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
    Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SC lipid model membranes designed for studying impact of ceramide species on drug diffusion and permeation--part II: diffusion and permeation of model drugs.
    Ochalek M; Podhaisky H; Ruettinger HH; Wohlrab J; Neubert RH
    Eur J Pharm Biopharm; 2012 Oct; 82(2):360-6. PubMed ID: 22750439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asymmetry of diffusion permeability of bi-layer membranes.
    Filippov AN; Starov VM; Kononenko NA; Berezina NP
    Adv Colloid Interface Sci; 2008 Jun; 139(1-2):29-44. PubMed ID: 18371928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of γ-cyclodextrin effect on permeation of lipophilic drugs: application of cellophane/fused octanol membrane.
    Muankaew C; Jansook P; Loftsson T
    Pharm Dev Technol; 2017 Jun; 22(4):562-570. PubMed ID: 27146583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transporters--the view from industry.
    Kohl C
    Chem Biodivers; 2009 Nov; 6(11):1988-99. PubMed ID: 19937835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transport properties and aggregation phenomena of polyoxyethylene sorbitane monooleate (polysorbate 80) in pig gastrointestinal mucin and mucus.
    Lafitte G; Thuresson K; Jarwoll P; Nydén M
    Langmuir; 2007 Oct; 23(22):10933-9. PubMed ID: 17894509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
    Sugano K
    Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclodextrins and drug permeability through semi-permeable cellophane membranes.
    Loftsson T; Másson M; Sigurdsson HH
    Int J Pharm; 2002 Jan; 232(1-2):35-43. PubMed ID: 11790488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.